Literature DB >> 30980738

The need for dried plasma - a national issue.

Anthony E Pusateri1, Frank K Butler2, Stacy A Shackelford3, Jason L Sperry4, Ernest E Moore5, Andrew P Cap1, Audra L Taylor6, Mary J Homer7, W Keith Hoots8, Richard B Weiskopf9, Michael R Davis10.   

Abstract

Recent studies have demonstrated that early transfusion of plasma or RBCs improves survival in patients with severe trauma and hemorrhagic shock. Time to initiate transfusion is the critical factor. It is essential that transfusion begin in the prehospital environment when transport times are longer than approximately 15 to 20 minutes. Unfortunately, logistic constraints severely limit the use of blood products in the prehospital setting, especially in military, remote civilian, and mass disaster circumstances, where the need can be most acute. US military requirements for logistically supportable blood products are projected to increase dramatically in future conflicts. Although dried plasma products have been available and safely used in a number of countries for over 20 years, there is no dried plasma product commercially available in the United States. A US Food and Drug Administration-approved dried plasma is urgently needed. Considering the US military, disaster preparedness, and remote civilian trauma perspectives, this is an urgent national health care issue.
© 2019 AABB.

Entities:  

Mesh:

Year:  2019        PMID: 30980738     DOI: 10.1111/trf.15261

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  7 in total

1.  Association of Prehospital Plasma Transfusion With Survival in Trauma Patients With Hemorrhagic Shock When Transport Times Are Longer Than 20 Minutes: A Post Hoc Analysis of the PAMPer and COMBAT Clinical Trials.

Authors:  Anthony E Pusateri; Ernest E Moore; Hunter B Moore; Tuan D Le; Francis X Guyette; Michael P Chapman; Angela Sauaia; Arsen Ghasabyan; James Chandler; Kevin McVaney; Joshua B Brown; Brian J Daley; Richard S Miller; Brian G Harbrecht; Jeffrey A Claridge; Herb A Phelan; William R Witham; A Tyler Putnam; Jason L Sperry
Journal:  JAMA Surg       Date:  2020-02-19       Impact factor: 14.766

2.  News Feature: Making and storing blood to save lives.

Authors:  Leah Shaffer
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-01       Impact factor: 11.205

Review 3.  Pathophysiology of Hemorrhage as It Relates to the Warfighter.

Authors:  Carmen Hinojosa-Laborde; Ian L Hudson; Evan Ross; Lusha Xiang; Kathy L Ryan
Journal:  Physiology (Bethesda)       Date:  2022-01-10

4.  Prehospital plasma is associated with distinct biomarker expression following injury.

Authors:  Danielle S Gruen; Joshua B Brown; Francis X Guyette; Yoram Vodovotz; Pär I Johansson; Jakob Stensballe; Derek A Barclay; Jinling Yin; Brian J Daley; Richard S Miller; Brian G Harbrecht; Jeffrey A Claridge; Herb A Phelan; Matthew D Neal; Brian S Zuckerbraun; Timothy R Billiar; Jason L Sperry
Journal:  JCI Insight       Date:  2020-04-23

Review 5.  Targeting repair of the vascular endothelium and glycocalyx after traumatic injury with plasma and platelet resuscitation.

Authors:  Mark Barry; Shibani Pati
Journal:  Matrix Biol Plus       Date:  2022-03-17

6.  The need for an artificial oxygen carrier for disasters and pandemics, including COVID-19.

Authors:  Richard B Weiskopf; Elon Glassberg; Nicole R Guinn; Michael F M James; Paul M Ness; Anthony E Pusateri
Journal:  Transfusion       Date:  2020-11-20       Impact factor: 3.337

7.  Freeze-Drying of Platelet-Rich Plasma: The Quest for Standardization.

Authors:  Isabel Andia; Arantza Perez-Valle; Cristina Del Amo; Nicola Maffulli
Journal:  Int J Mol Sci       Date:  2020-09-20       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.